Liang CK |
------>authors3_c=?? ------>paper_class1=1 ------>Impact_Factor=1.100 ------>paper_class3=2 ------>paper_class2=1 ------>vol=16 ------>confirm_bywho=None ------>insert_bywho=wmhsu ------>Jurnal_Rank=75.0 ------>authors4_c=??? ------>comm_author= ------>patent_EDate=None ------>authors5_c=?? ------>publish_day=1 ------>paper_class2Letter=None ------>page2=310 ------>medlineContent= ------>unit=E0115 ------>insert_date=20081205 ------>iam=4 ------>update_date=None ------>author=??? ------>change_event=6 ------>ISSN= ------>authors_c=??? ------>score=500 ------>journal_name=Complementary Therapies in Medicine ------>paper_name=A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial ------>confirm_date=20081205 ------>tch_id=096076 ------>pmid=19028329 ------>page1=305 ------>fullAbstract=OBJECTIVE: This study was designed to compare the reduction in myopia progression in patients treated with atropine eyedrops alone with patients treated with a combined treatment of atropine and stimulation of the auricular acupoints. METHODS: This study was a randomized single-blind clinical controlled trial. A total of 71 school-aged children with myopia, who fulfilled the eligibility criteria, were recruited. They were randomly assigned into three groups. These were 22 treated with the 0.25% atropine (0.25A) only, 23 treated with the 0.5% atropine (0.5A) only and 26 treated with 0.25% atropine together with stimulation of the auricular acupoints (0.25A+E). The differences in the post-treatment effects among these three groups were statistically assessed. The primary outcome parameter was myopia progression, which was defined as diopter change per year (D/Y) after cycloplegic refraction measurement. RESULTS: The mean myopia progression of the 0.25A group was 0.38+/-0.32 D/Y. No significant difference in mean myopia progression was found between the 0.5A (0.15+/-0.15 D/Y) and 0.25A+E (0.21+/-0.23 D/Y) groups. However, there was a markedly reduced myopia progression in the 0.25A+E group compared to the 0.25A group (p<0.05). Furthermore, there was no statistical difference among these three groups in axial length elongation (ALE) of eye during this stage of the investigation. CONCLUSIONS: This study demonstrates that there was efficacy in stimulating the auricular acupoints and this enhanced the action of 0.25% atropine as a means of myopia control. The result was an effect almost equal to that of 0.5% atropine alone. There is also a need that the ALE of the eye should be further investigated over a longer period using the combined therapy. ------>tmu_sno=None ------>sno=20505 ------>authors2=Ho TY ------>authors3=Li TC ------>authors4=Hsu WM ------>authors5=Li TM ------>authors6=Lee YC, IT Liu, Chang SL ------>authors6_c=??? ??? ------>authors=Liang CK ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c=?? ------>publish_area=0 ------>updateTitle=A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial. ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no= ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2008 ------>submit_flag=None ------>publish_month=12 |